keep off atezolizumab Generic Name: atezolizumab (A te zoe LIZ ue mab) Brand Name: Tecentriq Overview Side Effects Dosage Professional Interactions More Pregnancy Warnings User Reviews Support Group Q & A What is atezolizumab? Atezolizumab is a monoclonal antibody that affects the actions of the body's immune system. Atezolizumab strengthens your immune system to help your body fight against tumor cells. Atezolizumab is used to treat a certain type of bladder cancer that has spread to other parts of the body or cannot be removed by surgery. Atezolizumab is also used to treat non-small cell lung cancer that has spread to other parts of the body. Atezolizumab is usually given after other cancer medicines have been tried without success. Atezolizumab may also be used for purposes not listed in this medication guide. Slideshow The Ferocity of Chemotherapy - Does The End Justify The Means? What is the most important information I should know about atezolizumab? Atezolizumab strengthens your immune system to help your body fight against tumor cells. This may cause the immune system to attack normal healthy tissues or organs. When this happens, you may develop serious or life-threatening medical problems. Call your doctor at once if you have new or worsening symptoms such as: cough, breathing problems, changes in appetite or weight, diarrhea, stomach pain, vision problems, increased thirst or urination, yellowing of the skin or eyes, mood or behavior changes, severe muscle weakness, or numbness and tingling. What should I discuss with my healthcare provider before receiving atezolizumab? You should not use atezolizumab if you are allergic to it. To make sure atezolizumab is safe for you, tell your doctor if you have: an active infection; an immune system disorder such as lupus, ulcerative colitis, or Crohn's disease; a history of organ transplant; a breathing disorder; liver disease; or a nervous system disorder such as myasthenia gravis or Guillain Barré syndrome. Do not use atezolizumab if you are pregnant. It could harm the unborn baby. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 5 months after your last dose. It is not known whether atezolizumab passes into breast milk or if it could harm a nursing baby. You should not breast-feed while using this medicine or within 5 months after your last dose. If you use a breast pump during this time, throw out any milk you collect. Do not feed it to your baby. How is atezolizumab given? Read all patient information, medication guides, and instruction sheets provided to you. Ask your doctor or pharmacist if you have any questions. Atezolizumab is injected into a vein through an IV. A healthcare provider will give you this injection. This medicine is given slowly and the IV infusion can take up to 60 minutes to complete. Atezolizumab is usually given once every 3 weeks until your body no longer responds to the medication. Atezolizumab can increase your risk of infection by changing the way your immune system works. You will need frequent medical tests. What happens if I miss a dose? Call your doctor for instructions if you miss an appointment for your atezolizumab injection. What happens if I overdose? Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. What should I avoid while receiving atezolizumab? Follow your doctor's instructions about any restrictions on food, beverages, or activity. Atezolizumab side effects Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Some side effects may occur during the injection. Tell your caregiver right away if you feel dizzy, light-headed, chilled or feverish, itchy, or have neck pain, back pain, trouble breathing, or swelling in your face. Call your doctor at once if you have: new or worsening cough, chest pain, feeling short of breath; diarrhea, bloody or tarry stools; nausea or vomiting; severe stomach pain (especially in your upper stomach or spreading to your back); a light-headed feeling, like you might pass out; blurred vision, double vision, eye pain or redness; signs of infection--fever, flu symptoms, cough, painful or frequent urination; liver problems--loss of appetite, drowsiness, easy bruising or bleeding, dark urine, jaundice (yellowing of the skin or eyes); nervous system problems--neck stiffness, increased sensitivity to light, confusion, severe muscle weakness, numbness or tingling in your hands or feet; or signs of a hormonal disorder--frequent or unusual headaches, feeling light-headed or very tired, mood or behavior changes, hoarse or deepened voice, increased hunger or thirst, increased urination, nausea, vomiting, constipation, hair loss, feeling cold, weight gain, or weight loss. Your cancer treatments may be delayed or permanently discontinued if you have certain side effects. Common side effects may include: nausea, loss of appetite; constipation; tiredness; or urination problems. This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. Side Effects (complete list) Atezolizumab dosing information Usual Adult Dose for Non-Small Cell Lung Cancer: 1200 mg IV over 60 minutes every 3 weeks until disease progression or unacceptable toxicity Comments: -If the first infusion is tolerated, all subsequent infusions may be delivered over 30 minutes. -Do not administer this drug as an IV push or bolus. Use: For the treatment of patients with locally advanced or metastatic urothelial carcinoma who: -Have disease progression during or following platinum-containing chemotherapy -Have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy Uses: -For the treatment of patients with locally advanced or metastatic urothelial carcinoma who: 1) Are not eligible for cisplatin-containing chemotherapy 2) Have disease progression during or following platinum-containing chemotherapy, or have disease progression within 12 months of neoadjuvant or adjuvant chemotherapy -For the treatment of patients with metastatic non-small cell lung cancer (NSCLC) who have disease progression during or following platinum-containing chemotherapy. Patients with EGFR or ALK genomic tumor aberrations should have disease progression on FDA-approved therapy for these aberrations prior to receiving this drug Usual Adult Dose for Urothelial Carcinoma: 1200 mg IV over 60 minutes every 3 weeks until disease progression or unacceptable toxicity Comments: -If the first infusion is tolerated, all subsequent infusions may be delivered over 30 minutes. -Do not administer this drug as an IV push or bolus. Use: For the treatment of patients with locally advanced or metastatic urothelial carcinoma who: -Have disease progression during or following platinum-containing chemotherapy -Have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy Uses: -For the treatment of patients with locally advanced or metastatic urothelial carcinoma who: 1) Are not eligible for cisplatin-containing chemotherapy 2) Have disease progression during or following platinum-containing chemotherapy, or have disease progression within 12 months of neoadjuvant or adjuvant chemotherapy -For the treatment of patients with metastatic non-small cell lung cancer (NSCLC) who have disease progression during or following platinum-containing chemotherapy. Patients with EGFR or ALK genomic tumor aberrations should have disease progression on FDA-approved therapy for these aberrations prior to receiving this drug What other drugs will affect atezolizumab? Other drugs may interact with atezolizumab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using. Next Side Effects Print this page Add to My Med List More about atezolizumab Side Effects During Pregnancy Dosage Information Drug Interactions Support Group En Español 1 Review Add your own review/rating Drug class: Anti-PD-1 monoclonal antibodies Consumer resources Atezolizumab Atezolizumab Intravenous (Advanced Reading) Other brands: Tecentriq Professional resources Atezolizumab (AHFS Monograph) Related treatment guides Bladder Cancer Non-Small Cell Lung Cancer Urothelial Carcinoma Where can I get more information? Your pharmacist can provide more information about atezolizumab. Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed. Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist. Copyright 1996-2012 Cerner Multum, Inc. Version: 1.03. Last reviewed: May 05, 2017 Date modified: December 03, 2017} Drug Status Rx Availability Prescription only N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Drug Class Anti-PD-1 monoclonal antibodies Related Drugs Non-Small Cell Lung Cancer Avastin , methotrexate , Taxol , Opdivo , cisplatin , Taxotere , Tarceva , Keytruda , More... Bladder Cancer cisplatin , Adriamycin , doxorubicin , mitomycin , Tecentriq , thiotepa , Platinol , Mutamycin , More... Urothelial Carcinoma Opdivo , Keytruda , nivolumab , pembrolizumab , Tecentriq , Imfinzi , avelumab , durvalumab , More... Atezolizumab Rating 1 User Review 1 User Review Not Rated - Be the first! Help and Support Looking for answers? Ask a question or go join the atezolizumab support group to connect with others who have similar interests.} } Most worthy
let you atezolizumab and you are going
EmoticonEmoticon